^
1d
Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial. (PubMed, BMC Cancer)
This trial has been approved by the Institutional Review Board (IRB) and began patient enrollment in January 2024. The trial will provide insights into the safety and effectiveness of a novel combinatorial therapy for BCBM.
P1 data • Journal
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive
|
Herceptin (trastuzumab) • capecitabine • Tukysa (tucatinib)
1d
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer. (PubMed, Cancer Chemother Pharmacol)
DPYD rs4294451 T-allele count and male sex were significantly associated with reduced 5-FU drug exposure. DPYD rs4294451 and male sex merit further evaluation as candidate biomarkers to inform initial dosing of infusional 5-FU.
Journal
|
DPYD (Dihydropyrimidine Dehydrogenase)
|
5-fluorouracil
1d
Journal
|
DPYD (Dihydropyrimidine Dehydrogenase)
|
5-fluorouracil
2d
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study. (PubMed, Ecancermedicalscience)
Serum COX-2 levels did not show a significant change with capecitabine-based therapy, regardless of the use of topical diclofenac possibly reflecting the predominant stromal production of the enzyme. This finding highlights the need to assess HFS-affected tissues for local COX-2 immuno-expression along with further blood-based biomarkers.
Journal
|
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
|
capecitabine
2d
Overcoming diagnostic pitfalls in primary gastric squamous cell carcinoma: the imperative of adequate sampling in an elderly female patient, case report. (PubMed, Front Oncol)
Given the patient's advanced age, poor physical condition, and refusal of surgery, a palliative treatment plan of "Raltitrexed + Sintilimab" was finally decided upon after a multidisciplinary consultation. This case highlights the importance of adequate sampling in the diagnosis of gastric squamous cell carcinoma to avoid misdiagnosis due to limited specimens. It also provides a potential treatment option of immune therapy combined with low-dose chemotherapy for elderly patients with gastric squamous cell carcinoma who are not suitable for surgery.
Journal
|
TP63 (Tumor protein 63) • MUC5AC (Mucin 5AC)
|
Tyvyt (sintilimab) • Tomudex (raltitrexed)
2d
A rare case of undifferentiated embryonal sarcoma of the liver in an elderly patient misdiagnosed as intrahepatic cholangiocarcinoma. (PubMed, Int J Surg Case Rep)
UESL should be included in the differential diagnosis of atypical liver masses, even in elderly patients. Early surgical resection offers the best chance for survival, though outcomes remain dismal in advanced age due to rapid recurrence and metastasis. Heightened awareness of this entity is crucial to mitigate diagnostic delays.
Journal
|
NCAM1 (Neural cell adhesion molecule 1) • VIM (Vimentin) • MME (Membrane Metalloendopeptidase) • CA 19-9 (Cancer antigen 19-9)
|
capecitabine
2d
SHOOL: Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer (clinicaltrials.gov)
P=N/A, N=150, Not yet recruiting, Rajiv Gandhi Cancer Institute & Research Center, India
New trial
|
capecitabine • oxaliplatin • irinotecan
2d
HASCHANGE02: Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach (clinicaltrials.gov)
P2, N=30, Recruiting, Peking University Cancer Hospital & Institute | Not yet recruiting --> Recruiting
Enrollment open
|
Tyvyt (sintilimab) • albumin-bound paclitaxel • oxaliplatin • Teysuno (gimeracil/oteracil/tegafur)
3d
Laser-activated NGQDs boost the therapeutic response of 5-FU in breast cancer cells. (PubMed, Biomed Pharmacother)
This study investigates the role of nitrogen-doped graphene quantum dots (NGQDs) in enhancing the therapeutic efficacy of 5-fluorouracil (5-FU) in MDA-MB-231 cells under 660 nm diode laser irradiation with 100 mW Laser power...Results showed increased sensitivity of the MDA-MB-231 cells to the 5-FU and decreased ability to maintain redox equilibrium. These findings highlight the crucial role of NGQDs in facilitating triplet state formation and robust ROS generation, ultimately potentiating 5-FU's anticancer efficacy and paving the way for innovative combinational therapies.
Journal
|
CAT (Catalase)
|
5-fluorouracil
3d
New P2 trial • Minimal residual disease • Circulating tumor DNA
|
5-fluorouracil • capecitabine • oxaliplatin
4d
Identification and in silico evaluation of natural compounds from Annona muricata (soursop) leaves for colon cancer treatment. (PubMed, Sci Rep)
Results demonstrated that these phytochemicals exhibited superior binding affinities compared to standard therapy, 5-fluorouracil, with alpha-tocopherol notably outperforming it...Stability assessments showed consistent parameters throughout the simulation. Overall, the prioritized phytochemicals from A. muricata, especially alpha-tocopherol, exhibit significant anticancer potential and stability, supporting further experimental validation and development as therapeutic agents for colon cancer.
Journal
|
MLH1 (MutL homolog 1)
|
5-fluorouracil
4d
Chidamide enhances the sensitivity of gastric cancer to 5-fluorouracil chemotherapy by suppressing the HDAC3/HNF4A/TYMS axis. (PubMed, Cell Death Dis)
Chidamide promoted the sensitivity of GC to 5-FU by suppressing the HDAC3/HNF4A/TYMS axis. This research may provide a foundation for using chidamide to counteract resistance to 5-FU in GC.
Journal
|
TYMS (Thymidylate Synthetase) • HDAC3 (Histone Deacetylase 3) • HNF1A (HNF1 Homeobox A)
|
5-fluorouracil • Epidaza (chidamide)